osteosarcoma

You have access
Synergistic Effects of Melatonin on Radiosensitization in Carbon-ion Radiotherapy
MENGYANG JU, KAZUMASA MINAMI, SHOHEI KATSUKI, WATARU TAKENAKA, SHOTARO TATEKAWA, KEISUKE TAMARI, MASAHIKO KOIZUMI, YUTAKA TAKAHASHI and KAZUHIKO OGAWA

Anticancer Research August 2024, 44 (8) 3295-3306; DOI: https://doi.org/10.21873/anticanres.17148
Open Access
Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board
SANT P. CHAWLA, BRIAN VAN TINE, NOAH FEDERMAN, JOSEPH SCHWAB, ROBIN JONES, VIVEK SUBBIAH, NEAL S. CHAWLA, NIMA AFSHAR, WILLY HOOS, NANCY FELDMAN, H. TRENT SPENCER, WILLIAM SWANEY and ERLINDA M. GORDON

Anticancer Research July 2024, 44 (7) 2765-2768; DOI: https://doi.org/10.21873/anticanres.17139
Open Access
Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression
YUSUKE AOKI, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research July 2024, 44 (7) 2787-2792; DOI: https://doi.org/10.21873/anticanres.17090
You have access
Combined Auranofin and Celecoxib Suppresses the Local Progression and Pulmonary Metastases of Osteosarcoma In Vivo
HIDEYUKI KINOSHITA, SEIKO KINOSHITA, HIROTO KAMODA, YOKO HAGIWARA, SEIJI OHTORI and TSUKASA YONEMOTO

Anticancer Research March 2024, 44 (3) 1045-1049; DOI: https://doi.org/10.21873/anticanres.16899
You have access
Repurposing of Loperamide as a New Drug With Anticancer Activity for Human Osteosarcoma
LAURA RONCUZZI, FRANCESCA PERUT and NICOLA BALDINI

Anticancer Research March 2024, 44 (3) 1063-1070; DOI: https://doi.org/10.21873/anticanres.16901
You have access
Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library
YUKI YADA, KUNIHIRO ASANUMA, TAKUYA KAKIMTO, KAZUMA OKUNO, TAKAYUKI OKAMOTO, TAKAHIRO IINO, TOMOKI NAKAMURA and AKIHIRO SUDO

Anticancer Research March 2024, 44 (3) 1071-1078; DOI: https://doi.org/10.21873/anticanres.16902
Open Access
The Effect of Photodynamic Therapy Using 5-Aminolevulinic Acid in Bone and Soft Tissue Sarcoma Cells
RYOHEI ADACHI, TOMOKI NAKAMURA, KENTA NAKATA, TERUYA UCHIYAMA, TOMOHITO HAGI, KUNIHIRO ASANUMA and AKIHIRO SUDO

Anticancer Research March 2024, 44 (3) 963-969; DOI: https://doi.org/10.21873/anticanres.16891
You have access
BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell Lines
CLEMENS LANG, SANDRA STICKLER, BARBARA RATH, MARYANA TEUFELSBAUER, LUKAS WEIGL, MARTIN HOHENEGGER and GERHARD HAMILTON

Anticancer Research March 2024, 44 (3) 971-980; DOI: https://doi.org/10.21873/anticanres.16892
You have access
Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells
CHUN-YI LI, HSIN-CHUAN CHEN, CHIH-YING LIAO, FEI-TING HSU, KUANG-CHEN HUNG, KUO-CHING LIU, JAW-CHYUN CHEN and MING-CHOU KU

Anticancer Research January 2024, 44 (1) 85-92; DOI: https://doi.org/10.21873/anticanres.16790
You have access
Synergistic VSV Virotherapy and Carbon Nanotube Photothermal Therapy for Osteosarcoma in Murine Models
TOMOHIKO SAKUDA, AKIHIRO ODA, TAISUKE FURUTA, MUHAMMAD PHETRUS JOHAN, TAKEMASA SAKAGUCHI and NOBUO ADACHI

Anticancer Research January 2024, 44 (1) 99-105; DOI: https://doi.org/10.21873/anticanres.16792

Main menu

User menu

Search

osteosarcoma

Pages